| Trafigura Acquires Additional Shares in EMED | |
| | |
|
NICOSIA, CYPRUS--(Marketwired - Aug 26, 2014) - EMED Mining Public Limited (TSX: EMD) (AIM: EMED)
Trafigura Acquires Additional Shares in EMED The Company has been notified that Trafigura Beheer B.V. ("Trafigura") has, through its wholly owned indirect subsidiary Urion Holdings (Malta) Limited ("Urion"), acquired 30,856,481 ordinary shares ("Ordinary Shares") of EMED effective 21 Aug 2014, pursuant to private transactions. The Ordinary Shares were purchased by Urion for a value of GBP 0.09 per Ordinary Share (approximately $0.1633 Cdn. per Ordinary Share). Trafigura now exercises control or direction over an aggregate of 259,029,997 Ordinary Shares, representing approximately 18.04% of the outstanding Ordinary Shares. Trafigura has stated that it has acquired the Ordinary Shares for investment purposes. Depending on market and other conditions, Trafigura may change its beneficial ownership of, or control or direction over, Ordinary Shares through market transactions, private agreements, treasury issuances or otherwise. Trafigura has no role in management of EMED and has not appointed any nominees to the Board of Directors of EMED.
Enquiries
EMED Mining |
Isaac Querub/Alberto Lavandeira |
+34 959 59 28 50 |
RFC Ambrian |
Samantha Harrison |
+44 203 440 6800 |
Fox-Davies Capital |
Oliver Stansfield |
+44 203 463 5061 |
Walbrook Communications |
Nick Rome |
+44 207 933 8783 |
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |